Apogee Therapeutics (APGE) Accounts Payables (2022 - 2026)
Apogee Therapeutics (APGE) posted quarterly Accounts Payables of $1.2 million for Q1 2026, down 49.41% year-over-year from $2.4 million in Q1 2025, and up 1.31% quarter-over-quarter from $1.2 million in Q4 2025.
Apogee Therapeutics (APGE) Accounts Payables (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has reported Accounts Payables for 5 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 49.41% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 49.41% YoY), while the FY2025 annual figure was $1.2 million, up 14.01% from the prior year.
- Accounts Payables climbed to $1.2 million in Q1 2026 per APGE's latest filing, from $1.2 million in the prior quarter.
- Across five years, Accounts Payables topped out at $11.1 million in Q2 2023 and bottomed at $376000.0 in Q3 2025.
- Historically, Accounts Payables has averaged $3.0 million across 5 years, with a median of $2.1 million in 2023.
- Annual changes were most pronounced in 2023 — Accounts Payables soared 412.68% — and 2025, when it sank 83.03%.
- Apogee Therapeutics' Accounts Payables stood at $418000.0 in 2022, then jumped by 412.68% to $2.1 million in 2023, then sank by 50.02% to $1.1 million in 2024, then increased by 14.01% to $1.2 million in 2025, then grew by 1.31% to $1.2 million in 2026.
- Business Quant data shows APGE's Accounts Payables at $1.2 million in Q1 2026, $1.2 million in Q4 2025, and $376000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Apogee Therapeutics | 10.14 Bn | 9.16 Bn | - | 3.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.08 Mn |
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 376,000.00 |
| Jun 30, 2025 | 5.68 Mn |
| Mar 31, 2025 | 2.45 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 5.53 Mn |
| Mar 31, 2024 | 4.30 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 11.15 Mn |
| Dec 31, 2022 | 418,000.00 |